Tag: SCI

New network aims to “unlock” UK research potential in spinal cord...

Through the Spinal Cord Injury Clinical Research Network (CRN), which was formally launched in April to bring together clinicians, academics, researchers and possible funders...

Red light therapy demonstrates promise in spinal cord injury models

Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light. This method—invented by University...

New clinical practice guidelines aim to standardise spinal cord injury care

Following the recent publication of clinical practice guidelines for spinal cord injury (SCI), leading authors Michael G Fehlings and Mohammed Ali Alvi (both Toronto,...

Onward Medical awarded US FDA Breakthrough Device designation for ARC-BCI system

Onward Medical announced recently that it has been awarded Breakthrough Device designation (BDD) by the US Food and Drug Administration (FDA) for the ARC-BCI...

Nanomedicine may help deliver targeted therapy for spinal cord injury

Researchers in Italy have demonstrated that an innovative nanovector (nanogel)—which they developed—is able to deliver anti-inflammatory drugs in a targeted manner into glial cells actively involved...

SpineX close to full recruitment for SCONE clinical trial

SpineX has announced that it is close to full recruitment of the patient cohort for a clinical trial of its proprietary SCONE device, recently...

Variability in early surgery for acute cervical spinal cord injury patients

Following their recent publication in the Journal of Neurotrauma—which identified variability across acute cervical spinal cord injury (SCI) patients undergoing early surgery—several study authors...

Onward announces first-in-human implant of ARC-IM stimulator with wireless BCI device

Onward Medical has today announced the successful first-in-human implant of its ARC-IM stimulator intended to restore upper-extremity function after spinal cord injury (SCI). The...

NeuroSolv seeks to expand development and approval of novel spinal cord...

In partnership with AscellaHealth, NeuroSolv Therapeutics is seeking to expand the clinical trial development programme and accelerate regulatory approval procedures to optimise the prospect...

US Department of Defense grants University of Miami researcher $3.25 million...

Emad Ibrahim, director of the Male Fertility Research Program at The Miami Project to Cure Paralysis and the clinical andrology lab at the Desai...

Time is spine: A paradigm shift in the management of spinal...

 Michael Fehlings (Toronto, Canada) talks to Spinal News International at DWG-Kongress (7–9 December 2022; Berlin, Germany) about the “dramatic shift” over the past 25 years in...

Onward awarded grant to continue developing Brain-Computer Interface technology

Onward, a medical technology company creating therapies to restore movement and health in people with spinal cord injury (SCI), has been awarded a second...

ONWARD reveals positive topline results of LIFT Home study

ONWARD Medical has reported topline results from the LIFT Home study, which reported no serious adverse events and a 97% rate of successful session...

Researchers discover neural plastic changes that improve functional recovery after cervical...

Spinal cord and brain injury researchers at Indiana University School of Medicine (Indianapolis, USA), are studying new alternatives to promote functional recovery after a...

SATURN study highlights favourable outcomes for NeuorAiD in spinal cord injury...

NeuroAiD (MLC601/MLC901; Moleac) has a favourable safety profile and promising benefits as an add-on therapy to patients suffering from severe spinal cord injuries (SCIs)...

Spiderwort secures US$13.2 million in Series A financing

Spiderwort has announced the successful completion of its US$13.2 million Series A financing round, the money of which will be used to further develop its...

RECODE-DCM: Global consensus reached on degenerative cervical myelopathy as single unifying...

A global, multi-stakeholder consensus process involving those with lived experience has selected degenerative cervical myelopathy (DCM) as the single unifying term for a progressive...

Oligodendrocyte progenitor cells can be safely administered to patients in the...

Oligodendrocyte progenitor cells (LCTOPC1; Lineage Cell Therapeutics) can be safely administered to participants in the subacute period after cervical spinal cord injury (SCI), according...

Enrolment completed in ONWARD’s LIFT Home study

ONWARD Medical has announced that it has completed enrolment in the LIFT Home study, which is designed to evaluate the safety and performance of...

InVivo Therapeutics announces full enrolment for INSPIRE 2.0 acute spinal cord...

InVivo Therapeutics has completed enrolment in the INSPIRE 2.0 study for patients with acute spinal cord injury. The 20-patient study is a randomised, controlled...

ONWARD announces first-in-human use of its ARC implantable neurostimulator for spinal...

ONWARD Medical has announced the first patient enrolment in the HemON study and first-in-human use of the company’s ARC implantable pulse generator (IPG), which is...

First participants enrolled in ONWARD’s LIFT Home study

ONWARD has begun enrolment in the LIFT Home study, which is designed to examine the safety and performance of its ARCEX Therapy for spinal cord...

Novoron Bioscience raises US$3 million to boost neuroregeneration therapy for spinal...

Novoron Bioscience has secured US$3 million in seed funding which will go towards advancing the development of its of neuroregeneration therapy for spinal cord...

Precise blood pressure control may aid patient recovery from spinal cord...

High or low blood pressure in patients undergoing surgery to repair a spinal cord injury may contribute to poorer outcomes and maintaining an optimal...

Existing guidelines to change as research shows early surgical decompression following...

Surgical decompression within 24 hours of acute spinal cord injury (SCI) improves neurological recovery, and current guidelines on surgical management of SCI are being reviewed...

IU School of Medicine researchers discover new potential for functional recovery...

Researchers at Indiana University School of Medicine (Indianapolis, USA) have announced the successful reprogramming of a glial cell type in the central nervous system...

Lineage set for clinical testing with OPC transplant therapy for spinal...

Biotechnology outfit Lineage Cell Therapeutics has announced that it will return to clinical testing with its investigational allogeneic oligodendrocyte progenitor cell (OPC) transplant therapy...
How Cyclists get spinal injuries

A worrying trend in the spine centre referrals of cyclists

  Research that highlights a worrying trend between cycling and spinal trauma has recently been published in The Surgeon. Although the authors of the paper,...

Scientists map key brain-to-spinal cord nerve connections for voluntary movement

Researchers trying to help people suffering from paralysis after a spinal cord injury or stroke mapped critical brain-to-spinal cord nerve connections that drive voluntary...